| Literature DB >> 28955966 |
Alexandra Duque-Fernandez1,2, Lydia Gauthier1,2, Mélissa Simard1,2, Jessica Jean1, Isabelle Gendreau1, Alexandre Morin1, Jacques Soucy3, Michèle Auger4, Roxane Pouliot1,2.
Abstract
BACKGROUND: Inadequate representation of the human tissue environment during a preclinical screen can result in inaccurate predictions of compound effects. Consequently, pharmaceutical investigators are searching for preclinical models that closely resemble original tissue for predicting clinical outcomes.Entities:
Keywords: 3D-psoriatic skin model; Culture conditions; FTIR experiments; Pathogenesis; Percutaneous absorption; Physical characterization of the stratum corneum
Year: 2016 PMID: 28955966 PMCID: PMC5614463 DOI: 10.1016/j.bbrep.2016.09.012
Source DB: PubMed Journal: Biochem Biophys Rep ISSN: 2405-5808
Fig. 1Macroscopic aspects of healthy and psoriatic substitutes cultured with or without serum (scale bar=2 cm). The results were confirmed with cells from 3 (healthy substitutes) or 4 (psoriatic substitutes) patients (n=10 substitutes for each condition).
Fig. 2Masson's trichrome staining obtained from healthy and psoriatic substitutes cultured with or without serum. The results were confirmed with cells from 3 (healthy substitutes) or 4 (psoriatic substitutes) patients (n=3 substitutes for each condition) (scale bar=100 µm).
Fig. 3Proliferation and Differentiation markers. Ki-67, filaggrin and involucrin stainings of healthy substitutes cultured with (HS+S) or without (HS−S) serum, psoriatic substitutes cultured with (HS+S) or without (HS−S) serum; scale bar=100 µm. The results were confirmed with 3 experiments (total of six samples for each condition). Nuclei were stained with Hoechst. (Magnification×10). Percentage of positive Ki-67 cells are presented as mean±SD.
Fig. 4Stratum corneum lipid organization results obtained following ATR-FTIR spectroscopy analyses. Healthy substitutes with serum (HS+S), psoriatic substitutes with serum (PS+S), healthy substitutes cultured in serum-free condition (HS−S), psoriatic substitutes cultured in serum-free condition (PS−S), normal human skin (NHS) and psoriatic human skin (PHS). The results were confirmed with cells from 3 (healthy substitutes) or 4 (psoriatic substitutes) patients (n=3 substitutes for each condition).
Fig. 5Fluxes of hydrocortisone (A), benzoic acid (B) and caffeine (C) through healthy and psoriatic skin substitutes. The samples were taken after 0, 1, 2, 4, 6, 8 and 24 h. Healthy substitutes with serum (HS+S), healthy substitutes cultured in serum-free condition (HS−S), psoriatic substitutes with serum (PS+S), and psoriatic substitutes cultured in serum-free condition (PS−S). The results were confirmed with cells from 3 (healthy substitutes) or 4 (psoriatic substitutes) patients (n=3 substitutes for each condition).
Cumulative amount of hydrocortisone, benzoic acid and caffeine through the healthy and psoriatic skin substitutes cultured with or without serum. All data presented are the mean±standard deviation. The results were confirmed with cells from 3 (healthy substitutes) or 4 (psoriatic substitutes) patients (n=3 substitutes for each condition).
| HS+S | 4.24±2.27 | 12.20±5.92 | 57.50±10.80 |
| HS-S | 12.90±6.10 | 33.60±18.10 | 227.00±97.80 |
| PS+S | 129.00±67.30 | 332.00±140.00 | 896.00±99.40 |
| PS-S | 476.00±118.00 | 741.00±73.90 | 920.00±29.50 |
| HS+S | 1.87±0.84 | 4.71±1.16 | 68.30±3.59 |
| HS-S | 9.61±4.59 | 24.70±11.60 | 377.00±172.00 |
| PS+S | 86.00±23.50 | 189.00±75.40 | 433.00±141.00 |
| PS-S | 213.00±60.50 | 360.00±58.60 | 521.00±31.60 |
| HS+S | 5.38±0.75 | 17.90±1.95 | 132.00±7.40 |
| HS-S | 16.20±5.22 | 48.50±6.86 | 115.00±28.80 |
| PS+S | 55.90±16.00 | 85.20±22.10 | 102.00±24.90 |
| PS-S | 83.20±25.60 | 115.00±11.20 | 124.00±2.99 |
significant between HS+S and HS-S),
significant between PS+S and HS+S), and
significant between PS+S and PS-S).